Dr. Amelie Ramirez, chair of the Department of Population Health Sciences and associate director of Community Outreach and Engagement for the Mays Cancer Center, explains the importance of participation in clinical trials, the benefits for patients and how our doctors are at the forefront of cancer research.
Dr. Ramirez said there are 240 open clinical trials and less than 6% of individuals who sign up are of minority descent.
“By 2030, cancer in Latinos is supposed to increase by 142%,” Ramirez said. “But very little is known about our heterogeneity, we need to know more about how those drugs work with us.”
Ramirez said patients benefit because they are getting treatment, and in many cases, it’s the latest medical advancement.
Read and watch the story.
